| abstract |
(57) [Summary] Prevention of myocardial infarction or stroke; maintenance or improvement of vascular reactivity; treatment of acute or chronic renal failure, peripheral arterial occlusive disease, coronary artery disease, or Raynaud's phenomenon, or Lp (a) ) Provides a method for reducing plasma levels. The present invention provides for the prevention of myocardial infarction or stroke using an estrogen agonist / antagonist; the maintenance or improvement of vascular reactivity; acute or chronic renal failure; Provided are methods and kits for improving or maintaining vascular health, including treating peripheral arterial occlusive disease, coronary artery disease, or Raynaud's phenomenon; or reducing plasma levels of Lp (a). |